Impax Laboratories (NASDAQ:IPXL) reported Q4 2017 earnings this Morning, coming in at $0.11 per share, missing Wall Street’s estimates of $0.12 per Share. Revenue for the quarter came in at $182.90 million missing the streets estimates of $199.13 million Recent Insider Trading for Impax Laboratories (NASDAQ:IPXL)
- On 5/31/2017 Michael Nestor, Insider, sold 1,130 with an average share price of $15.00 per share and the total transaction amounting to $16,950.00.
- On 5/17/2017 Michael Nestor, Insider, sold 857 with an average share price of $16.48 per share and the total transaction amounting to $14,123.36.
- On 5/12/2017 Michael Nestor, Insider, sold 700 with an average share price of $17.11 per share and the total transaction amounting to $11,977.00.
- On 8/15/2016 Leslie Z Benet, Director, sold 10,092 with an average share price of $22.81 per share and the total transaction amounting to $230,198.52.
- On 9/11/2015 Mark A Schlossberg, SVP, sold 7,457 with an average share price of $43.30 per share and the total transaction amounting to $322,888.10.
- On 9/10/2015 Michael Nestor, Insider, sold 5,000 with an average share price of $43.56 per share and the total transaction amounting to $217,800.00.
Recent Trading for Impax Laboratories (NASDAQ:IPXL) Shares of Impax Laboratories closed the previous trading session at 19.90 down -0.50 2.45% with 16536 shares trading hands.